Latest & greatest articles for cannabis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cannabis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cannabis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cannabis

1. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain | Effective Health Care Program Search Effective Health Care website Submit search Toggle navigation Select site to search Search Effective Health Care website Submit search » » » Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain Living Systematic Review on Cannabis and Other Plant-Based (...) the accumulating evidence and are updated on a regular basis. They include a description of the available studies and an appraisal of study quality. January 2021 Update Overview This is the first progress report for an ongoing living systematic review on plant-based treatments for chronic pain. The systematic review will synthesize evidence on the benefits and harms of plant-based compounds (PBCs) such as cannabinoids and kratom used to treat chronic pain, addressing concerns about severe adverse effects

2021 Effective Health Care Program (AHRQ)

2. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial

Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) of print. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial , , , , , Affiliations Expand Affiliations 1 Department of Emergency Medicine, Queen's University, Kingston, Ontario, Canada. 2 Department of Emergency Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: marco.sivilotti@queensu.ca. PMID: 33160719 DOI: Item in Clipboard Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC

2021 EvidenceUpdates

3. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews

General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search (...) Page navigation Pain Actions . 2020 Jul 13. doi: 10.1097/j.pain.0000000000002000. Online ahead of print. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Anesthesiology and Perioperative Medicine, Kingston General Hospital, Queen's University, Kingston, ON, Canada. 2 University of Sydney Centre

2020 EvidenceUpdates

4. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest (...) : Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Pain Actions . 2020 May 28. doi: 10.1097/j.pain.0000000000001941. Online ahead of print. Cannabinoids, cannabis

2020 EvidenceUpdates

5. Chronic cannabis consumption and physical exercise performance in healthy adults: a systematic review Full Text available with Trip Pro

up to January 2020 using the following search terms: “Cannabi*” OR “marijuana” OR “marihuana” OR “THC” OR “tetrahydrocannabinol” OR “delta-9-tetrahydrocannabinol” OR “CBD” AND “Athlet*” OR “physical activity” OR “fitness” OR “exercise” OR “sport” OR “endurance” OR “VO2” OR “VO2Max”. The search and data abstraction were performed by AK, studies with potential relevance were reviewed by the other authors for inclusion. Studies were included if they: reported validated measures of athletic (...) of diabetes in marijuana users: cross-sectional data from the National Health and nutrition examination survey (NHANES) III. BMJ Open. 2012;2(1):1–9 . Renaud AMAM, Cormier Y. Acute effects of marihuana smoking on maximal exercise performance. Med Sci Sports Exerc. 1986;18(6):685–9 . Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344–64 . Steadward RD, Singh M. The effects of smoking marihuana on physical performance. Med Sci

2020 Journal of Cannabis Research

6. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association | Circulation Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 This site uses cookies. By continuing (...) to browse this site you are agreeing to our use of cookies. Free Access Review Article Share on Jump to Free Access Review Article Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association , PharmD, MSPH, FAHA, Chair , MD, MHS, FAHA, Vice Chair , MD, PhD , PhD , PhD , MD, MSc, FAHA , RN, PhD, FAHA , MD, PhD , MD, FAHA Robert L. Page II , Larry A. Allen , Robert A. Kloner , Colin R. Carriker , Catherine Martel , Alanna A. Morris

2020 American Heart Association

7. A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome

13;1(1):CD007393. doi: 10.1002/14651858.CD007393.pub4. Cochrane Database Syst Rev. 2017. PMID: 28085183 Free PMC article. Review. Show more similar articles References Gray KM, Watson NL, Christie DK. Challenges in quantifying marijuana use. Am J Addict 2009;18:178-9. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012;87:114-9. Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome (...) A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC

2020 EvidenceUpdates

8. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial Full Text available with Trip Pro

(SCD) is characterized by chronic pain and episodic acute pain caused by vasoocclusive crises, often requiring high doses of opioids for prolonged periods. In humanized mouse models of SCD, a synthetic cannabinoid has been found to attenuate both chronic and acute hyperalgesia. The effect of cannabis on chronic pain in adults with SCD is unknown. Objective: To determine whether inhaled cannabis is more effective than inhaled placebo in relieving chronic pain in adults with SCD. Design, setting (...) . Roy NB, Fortin PM, Bull KR, Doree C, Trivella M, Hopewell S, Estcourt LJ. Roy NB, et al. Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2. Cochrane Database Syst Rev. 2017. PMID: 28672087 Free PMC article. Review. Show more similar articles References National Conference of State Legislatures State medical marijuana laws. Accessed May 31, 2019. Kosiba JD, Maisto SA, Ditre JW. Patient-reported use of medical cannabis for pain, anxiety, and depression

2020 EvidenceUpdates

9. Therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis: protocol of a systematic review Full Text available with Trip Pro

Therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis: protocol of a systematic review Therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis: Protocol for a systematic review | medRxiv Search for this keyword Therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis: Protocol for a systematic review Clara Schulze , Josefina Durán , Rocío (...) Chile Associated Center, Pontificia Universidad Católica de Chile , Santiago, Chile 4 Internal Medicine Department, Faculty of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile For correspondence: ABSTRACT OBJECTIVE To assess the therapeutic effects of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis. DESIGN This is the protocol of a systematic review. DATA SOURCES: Searches will be conducted in PubMed/Medline, Embase, Cochrane Central

2020 Cold Spring Harbor Laboratory

10. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies Full Text available with Trip Pro

of Cannabis sativa , has been recently approved for treatment-resistant epilepsy. Seizures represent frequent medical comorbidities of ASD and could be responsible for the onset or worsening of behavioral problems. Thus, it has been hypothesized that cannabinoids could be useful in improving some ASD symptoms. Our systematic review was conducted according to the PRISMA guidelines and aimed to summarize the literature regarding the use of cannabinoids in ASD. After searching in Web of Knowledge TM (...) Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies[v1] | Preprints Share this article with Create alert Email: Submit > > > doi: 10.20944/preprints202007.0373.v1 Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies , , , , , , , * Version 1 : Received: 15 July

2020 MDPI AG

11. Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

with maternal marijuana use in the first trimester, but not for the second or third trimester was observed. As no new evidence was found in the updated search, there continues to be insufficient evidence to demonstrate an association between cannabis smoking and the incidence of cancer in offspring. Conclusion: There is insufficient evidence to demonstrate an association between parental cannabis use and subsequent risk of developing any malignancies in offspring. 7.Are cannabis or cannabinoids an effective (...) Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report Evidence Summary 23-2 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario) Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study

2020 Cancer Care Ontario

12. COVID 19, Alcohol and Cannabis Use

among critically ill patients admitted to an intensive care unit with an infection (Gacouin et al., 2020). The effects of cannabis use and cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), on immune functioning are complex and not yet well understood. However, a growing body of preclinical studies and several studies involving humans suggest that THC and CBD can affect the immune system, including suppressing its ability to mount a response to fight off infections (Cabral (...) COVID 19, Alcohol and Cannabis Use www.ccsa.ca • www.ccdus.ca Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage de substances Page 1 COVID-19, Alcohol and Cannabis Use This backgrounder to the infographic, COVID-19, Alcohol and Cannabis Use, describes some of the evidence-based associations between COVID-19, alcohol and cannabis use. It is intended for a broad audience, including health professionals, policy makers and researchers

2020 Canadian Centre on Substance Abuse

13. Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial

Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show (...) Permalink Copy Page navigation Obstet Gynecol Actions . 2020 Jun;135(6):1289-1295. doi: 10.1097/AOG.0000000000003850. Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial , , , , , , , Affiliations Expand Affiliation 1 Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon. PMID: 32459420 DOI: Item in Clipboard Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial Alyssa Covelli Colwill et al. Obstet

2020 EvidenceUpdates

14. Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis

Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Reg Anesth Pain Med Actions . 2020 Jul;45(7):509-519. doi: 10.1136/rapm-2020-101340. Epub 2020 May 28. Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis , , , Affiliations Expand Affiliations 1 Anesthesiology and Pain Medicine - North York General Hospital & The Ottawa Hospital, University of Toronto, University of Ottawa, Toronto, Ottawa, Ontario

2020 EvidenceUpdates

15. Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: A systematic review Full Text available with Trip Pro

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: A systematic review Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: A systematic review | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior (...) to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: A systematic review Babasola Okusanya, Ibitola O. Asaolu, John E. Ehiri, Linda Jepkoeach Kimaru, Abidemi Okechukwu, Cecilia Rosales Babasola Okusanya University of Arizona Mel and Enid

2020 Research Square

16. Counselling adolescents and parents about cannabis: A primer for health professionals

Counselling adolescents and parents about cannabis: A primer for health professionals While cannabis use among adolescents is frequent in Canada, youth do recognize the potential harms, and increasingly expect knowledgeable health care providers to discuss substance use in everyday practice. This practice point provides sound, evidence-based tools to help health professionals address non-medical (recreational) cannabis use and its related risks. After highlighting how to make the clinical (...) setting a safe space for youth to talk about psychoactive substances, specific strategies for approaching cannabis use in effective, developmentally appropriate ways are described. Consistent with current literature, screening questionnaires to help structure discussion and identify adolescents who may benefit from more specialized interventions are recommended. Because one in six adolescents who experiments with cannabis goes on to misuse it, appraising their willingness to change risky behaviours

2020 Canadian Paediatric Society

17. COVID-19 and Cannabis Smoking and Vaping: Four Things You Should Know

on the lung and immune defenses. In ElSohly (ed.), Marijuana and the Cannabinoids, pp. 253–275. Totowa, New Jersey: Humana Press. Taylor, D. R., Poulton, R., Moffit, T. E., Ramankutty, P., & Sears, M. R. (2000). The respiratory effects of cannabis dependence in young adults. Addiction, 95(11), 1669–1677. Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review (...) Group: https://www.cannabisrehab.org/ Cannabis Resources • Canadian Institute for Substance Use Research, Safer Cannabis Use: https://www.heretohelp.bc.ca/infosheet/safer-cannabis-use-marijuana-hash-hash-oil • Centre for Addiction and Mental Health, Canada’s Lower-Risk Cannabis Use Guidelines: https://www.camh.ca/-/media/files/pdfs---reports-and-books---research/canadas-lower-risk- guidelines-cannabis-pdf.pdf • Government of Canada, Cannabis in Canada: Get the facts: https://www.canada.ca/en

2020 Canadian Centre on Substance Abuse

18. Use of cannabinoids in cancer patients Full Text available with Trip Pro

f , x W. Burke Affiliations Stony Brook Medicine, Stony Brook, NY, USA c DOI: | Publication History Published online: January 13, 2020 Accepted: December 11, 2019 ; Received: October 24, 2019 ; To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Highlights • Tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabinol (CBN) affect the human endocannabinoid system. • Cannabinoids reduce chemotherapy induced nausea or vomiting (CINV (...) ) and neuropathic pain. • Each state has its own regulations for medical and recreational cannabis use. • Effects of cannabinoids on chemotherapy, immunotherapy, and tumor growth remain under investigation. • Providers should focus indications, alternatives, risks and benefits of medical cannabis use to make appropriate referrals. Keywords: , , , , , To access this article, please choose from the options below Log In Register Purchase access to this article Claim Access If you are a current subscriber

2020 Society of Gynecologic Oncology

19. Cannabis use and attention deficit/hyperactivity disorder: a systematic review Full Text available with Trip Pro

. [ ] 34. Notzon DP, Pavlicova M, Glass A, Mariani JJ, Mahony AL, Brooks DJ, et al. ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. J Atten Disord . 2016;10.1177/1087054716640109 [ ] 35. Murray RM, Quigley H, Quattrone D, Englund A, Forti MD. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry. 2016;15(3):195-204. [ ] 36. Fergusson DM, Boden JM. Cannabis use and adult ADHD symptoms. Drug Alcohol (...) Cannabis use and attention deficit/hyperactivity disorder: a systematic review Servicios Personalizados Revista Articulo Indicadores Citado por SciELO Links relacionados Similares en SciELO Compartir versión impresa ISSN 1816-8949 An. Fac. Cienc. Méd. (Asunción) vol.53 no.1 Asunción abr. 2020 ARTICULO ORIGINAL Uso de cannabis y trastorno por déficit de atención e hiperactividad: una revisión sistemática Cannabis use and attention deficit/hyperactivity disorder: a systematic review Julio César

2020 Anales de la Facultad de Ciencias Médicas (Asunción)

20. Cannabis- Based Reduction in Opioid-Related Harms: Population-Based Observational Meta-Analysis Full Text available with Trip Pro

. Rhetoric abounds about harms associated with easier access to cannabis. Yet, surveys of medical marijuana patients and recreational users in Canada and the USA observed that they prevalently substitute cannabis for alcohol, opioids and other drugs. This synthetic study focused on arguably the most harmful substance, opioids, and hypothesized reduced harms with medical and recreational cannabis legalization. Methods. Broad keyword searches of interdisciplinary research databases, peer-reviewed and gray (...) ways. However, all the studies, thus far, have been state-level, ecological analyses. Further multilevel and clinic-based analyses in ought to be accomplished to systematically replicate (or refute) this study’s harm reduction estimates and to put them into clinical practice where indicated. Keywords Cannabis, Marijuana, medical, recreational, prescription, illicit opioids, legalization, laws, policies Background Methods Results Discussion Conclusions Declarations References Tables Due to technical

2020 Research Square